Investors & Media

Overview

Webcast ImageWebcast
Deutsche Bank 41st Annual Health Care Conference  (Live)
05/04/16 at 2:10 p.m. ET
Deutsche Bank 41st Annual Health Care Conference
Wednesday, May 4, 2016 2:10 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Bank of America Merrill Lynch 2016 Health Care Conference (Live)
05/11/16 at 2:20 p.m. PT
Bank of America Merrill Lynch 2016 Health Care Conference
Wednesday, May 11, 2016 2:20 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. The company’s objective is to develop and bring to market the most advanced products based on the transformative potential of gene therapy to provide patients hope for a better life in the face of limited or no long-term safe and effective treatment options. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.

stock quote

NASDAQ: BLUE (common stock)

Refresh Quote
ExchangePriceChange (%)Volume
NASDAQ GS (US Dollar)
$45.09
 Stock is Down 1.22 (2.63%)
934,463
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Contact

Manisha Pai

Sr. Director, Investor Relations

(617) 245-2107

investor@bluebirdbio.com


Media Contact

Dan Budwick

Senior Vice President, Media Relations

Pure Communications Inc.

(973) 271-6085

dan@purecommunicationsinc.com